Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Vitamin D, vitamin D binding protein, and longitudinal outcomes in COPD.

Persson LJ, Aanerud M, Hiemstra PS, Michelsen AE, Ueland T, Hardie JA, Aukrust P, Bakke PS, Eagan TM.

PLoS One. 2015 Mar 24;10(3):e0121622. doi: 10.1371/journal.pone.0121622. eCollection 2015.

2.

Chronic obstructive pulmonary disease is associated with low levels of vitamin D.

Persson LJ, Aanerud M, Hiemstra PS, Hardie JA, Bakke PS, Eagan TM.

PLoS One. 2012;7(6):e38934. doi: 10.1371/journal.pone.0038934. Epub 2012 Jun 21.

3.

Vitamin D, vitamin D binding protein, lung function and structure in COPD.

Berg I, Hanson C, Sayles H, Romberger D, Nelson A, Meza J, Miller B, Wouters EF, Macnee W, Rutten EP, Romme EA, Vestbo J, Edwards L, Rennard S.

Respir Med. 2013 Oct;107(10):1578-88. doi: 10.1016/j.rmed.2013.05.010. Epub 2013 Jul 1.

4.

Prevalence, determinants and clinical correlates of vitamin D deficiency in patients with Chronic Obstructive Pulmonary Disease in London, UK.

Jolliffe DA, James WY, Hooper RL, Barnes NC, Greiller CL, Islam K, Bhowmik A, Timms PM, Rajakulasingam RK, Choudhury AB, Simcock DE, Hyppönen E, Walton RT, Corrigan CJ, Griffiths CJ, Martineau AR.

J Steroid Biochem Mol Biol. 2018 Jan;175:138-145. doi: 10.1016/j.jsbmb.2017.01.019. Epub 2017 Feb 1.

5.

Relationship of vitamin D status with lung function and exercise capacity in COPD.

Jung JY, Kim YS, Kim SK, Kim HY, Oh YM, Lee SM, Seo JB, Lee SD; KOLD Study.

Respirology. 2015 Jul;20(5):782-9. doi: 10.1111/resp.12538. Epub 2015 Apr 13.

6.

High Vitamin D-Binding Protein Concentration, Low Albumin, and Mode of Remission Predict Relapse in Crohn's Disease.

Ghaly S, Murray K, Baird A, Martin K, Prosser R, Mill J, Simms LA, Hart PH, Radford-Smith G, Bampton PA, Lawrance IC.

Inflamm Bowel Dis. 2016 Oct;22(10):2456-64. doi: 10.1097/MIB.0000000000000894.

PMID:
27631600
7.

Relationship between vitamin D-binding protein polymorphisms and blood vitamin D level in Korean patients with COPD.

Park Y, Kim YS, Kang YA, Shin JH, Oh YM, Seo JB, Jung JY, Lee SD.

Int J Chron Obstruct Pulmon Dis. 2016 Apr 7;11:731-8. doi: 10.2147/COPD.S96985. eCollection 2016.

8.

Clinical Utility of Measurement of Vitamin D-Binding Protein and Calculation of Bioavailable Vitamin D in Assessment of Vitamin D Status.

Kim HJ, Ji M, Song J, Moon HW, Hur M, Yun YM.

Ann Lab Med. 2017 Jan;37(1):34-38. doi: 10.3343/alm.2017.37.1.34.

9.

Vitamin D Binding Protein Is Not Involved in Vitamin D Deficiency in Patients with Chronic Kidney Disease.

Kalousova M, Dusilova-Sulkova S, Zakiyanov O, Kostirova M, Safranek R, Tesar V, Zima T.

Biomed Res Int. 2015;2015:492365. doi: 10.1155/2015/492365. Epub 2015 May 4.

10.

The relationship between Vitamin D status and exacerbation in COPD patients- a literature review.

Ferrari R, Caram LMO, Tanni SE, Godoy I, Rupp de Paiva SA.

Respir Med. 2018 Jun;139:34-38. doi: 10.1016/j.rmed.2018.04.012. Epub 2018 Apr 23. Review.

PMID:
29857999
11.

Association of Serum Vitamin D (25OHD) Level with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Islam S, Sarkar NK, Mujahid AA, Bennoor KS, Hossain SS, Attar MM, Jahan R, Hossain MA, Chowdhury HA, Ali L.

Mymensingh Med J. 2019 Apr;28(2):441-448.

PMID:
31086164
12.

Vitamin D-binding protein and free vitamin D concentrations in acromegaly.

Altinova AE, Ozkan C, Akturk M, Gulbahar O, Yalcin M, Cakir N, Toruner FB.

Endocrine. 2016 May;52(2):374-9. doi: 10.1007/s12020-015-0789-1. Epub 2015 Nov 7.

PMID:
26547217
13.

[The correlation of vitamin D level and vitamin D-binding protein gene polymorphism in chronic obstructive pulmonary disease].

Li X, Liu X, Xu Y, Xiong W, Zhao J, Ni W, Chen S.

Zhonghua Nei Ke Za Zhi. 2014 Apr;53(4):303-7. Chinese.

PMID:
24857306
14.

Prognostic value of C-reactive protein, leukocytes, and vitamin d in severe chronic obstructive pulmonary disease.

Moberg M, Vestbo J, Martinez G, Lange P, Ringbaek T.

ScientificWorldJournal. 2014 Jan 21;2014:140736. doi: 10.1155/2014/140736. eCollection 2014.

15.

No association of 25-hydroxyvitamin D with exacerbations in primary care patients with COPD.

Puhan MA, Siebeling L, Frei A, Zoller M, Bischoff-Ferrari H, Ter Riet G.

Chest. 2014 Jan;145(1):37-43. doi: 10.1378/chest.13-1296.

PMID:
24008868
16.

Serum magnesium and not vitamin D is associated with better QoL in COPD: A cross-sectional study.

Hashim Ali Hussein S, Nielsen LP, Konow Bøgebjerg Dolberg M, Dahl R.

Respir Med. 2015 Jun;109(6):727-33. doi: 10.1016/j.rmed.2015.03.005. Epub 2015 Mar 27.

17.

Serum vitamin D in patients with chronic obstructive lung disease does not correlate with mortality--results from a 10-year prospective cohort study.

Holmgaard DB, Mygind LH, Titlestad IL, Madsen H, Fruekilde PB, Pedersen SS, Pedersen C.

PLoS One. 2013;8(1):e53670. doi: 10.1371/journal.pone.0053670. Epub 2013 Jan 14.

18.

Prognostic value of circulating vitamin D binding protein, total, free and bioavailable 25-hydroxy vitamin D in patients with colorectal cancer.

Yang L, Chen H, Zhao M, Peng P.

Oncotarget. 2017 Jun 20;8(25):40214-40221. doi: 10.18632/oncotarget.16597.

19.

Relationship between vitamin D and lung function, physical performance and balance on patients with stage I-III chronic obstructive pulmonary disease.

Yumrutepe T, Aytemur ZA, Baysal O, Taskapan H, Taskapan CM, Hacievliyagil SS.

Rev Assoc Med Bras (1992). 2015 Mar-Apr;61(2):132-8. doi: 10.1590/1806-9282.61.02.132.

20.

Soluble receptor for advanced glycation end-products and progression of airway disease.

Iwamoto H, Gao J, Pulkkinen V, Toljamo T, Nieminen P, Mazur W.

BMC Pulm Med. 2014 Apr 24;14:68. doi: 10.1186/1471-2466-14-68.

Supplemental Content

Support Center